Navigation Links
NTI in Biological Technology

Medical Simulation Corporation to Introduce Central Line Management Program at the National Teaching Institute and Critical Care Exposition

...l be presented at the MSC Booth (#1951) during the nti Critical Care Exposition, May 19-21, with opportunities for all nti attendees to participate in both types of simulati..., including training options, will be available at nti and can also be found online at www.medsimulatio...

Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of Company

...result in a transaction that meets our objectives, nti will act expeditiously to return as much cash as p...potential new drug to treat acute ischemic stroke. nti has recently chosen not to extend its early-stage ...a collaborative agreement with the Buck Institute. nti has rights to receive payments from an approved dr...

Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial Results

...ed product candidate, Viprinex(TM) (ancrod), which was studied in Phase 3 clinical trials for evaluation as a new drug to treat acute ischemic stroke. nti has an early-stage development program for Alzheimer's disease and rights to receive payments on an approved drug for Alzheimer's disease and an inves...

Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine

... treatment of Alzheimer's disease. Under an exclusive marketing agreement, nti currently receives quarterly royalty payments on certain sales of Memantine...inical trials for evaluation as a new drug to treat acute ischemic stroke. nti has an early-stage development program for Alzheimer's disease and rights t...

Neurobiological Technologies Announces Suspension of Viprinex Development

...mum necessary to carry out operations and complete contractual obligations. nti is terminating a majority of its employees this week, with additional emplo...linical trials for evaluation as a new drug to treat acute ischemic stroke. nti also has early-stage development programs for Alzheimer's and Huntington's ...

Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009

...ic) has provided an update on XERECEPT(R). nti sold the worldwide rights and assets related to XERECEPT to Celtic in November 2005. nti is entitled to receive milestone payments upon the..., and if XERECEPT is approved for commercial sale, nti is also entitled to receive profit-sharing payment...

Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results

...trial, which we expect to complete by mid-2009." nti also announced that it has amended its stockholder...ed under the plan. Conference Call Information nti will webcast its quarterly financial results and h... which there are few acceptable treatment options. nti also has early-stage development programs for Alzh...

Neurobiological Technologies to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York on November 10

...nex has multiple mechanisms of action and is specifically designed to extend the time period that patients can be treated after the onset of a stroke. nti also has early-stage development programs for Alzheimer's and Huntington's diseases, rights to receive payments on an approved drug for Alzheimer's di...

Neurobiological Technologies Sets Date for First Quarter Financial Results

...cute ischemic stroke is one of the most prevalent, debilitating and costly diseases in the world for which there are few acceptable treatment options. nti also has early-stage development programs for Alzheimer's and Huntington's diseases and rights to receive payments on an approved drug for Alzheimer's...

Neurobiological Technologies Reports Receipt of $2 Million Royalty Payment for Quarterly Sales of Memantine

...rate-to-severe Alzheimer's disease. Under an exclusive marketing agreement, nti currently receives quarterly royalty payments on certain sales of Memantine...diseases in the world for which there are few acceptable treatment options. nti also has early-stage development programs for Alzheimer's and Huntington's ...

Neurobiological Technologies to Present at the BIO Investor Forum in San Francisco on October 30, 2008

...nex has multiple mechanisms of action and is specifically designed to extend the time period that patients can be treated after the onset of a stroke. nti also has early-stage development programs for Alzheimer's and Huntington's diseases, rights to receive payments on an approved drug for Alzheimer's di...

Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program

...cute ischemic stroke is one of the most prevalent, debilitating and costly diseases in the world for which there are few acceptable treatment options. nti also has early-stage development programs for Alzheimer's and Huntington's diseases and rights to receive payments on an approved drug for Alzheimer's...

Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit

...cute ischemic stroke is one of the most prevalent, debilitating and costly diseases in the world for which there are few acceptable treatment options. nti also has early-stage development programs for Alzheimer's and Huntington's diseases and rights to receive payments on an approved drug for Alzheimer's...

Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine

...harmaceuticals GmbH (Merz) for sales of Memantine for the treatment of moderate-to-severe Alzheimer's disease. Under an exclusive marketing agreement, nti currently receives quarterly royalty payments on certain sales of Memantine by Merz and its marketing partners. About Neurobiological Technologies, ...

Neurobiological Technologies' CEO to Retire on December 31, 2008

...s sufficient time to thoughtfully identify my successor. I will direct our operations with vigor over the next six months and continue to be an active nti director beyond my retirement." A committee has been formed by the Board of Directors, headed by NTI director, William A. Fletcher, Chairman of Teva...

Neurobiological Technologies Reports Third Quarter Financial Results

...ion. During the three months ended March 31, 2008, nti wrote-down the value of its auction rate securitie...anial hemorrhage." Conference Call Information nti will webcast its quarterly financial results and h...tients can be treated after the onset of a stroke. nti also has the right to receive royalty payments fro...

Neurobiological Technologies Sets Date for Third Quarter Financial Results

...e the time period that patients can be treated after the onset of a stroke. nti also has the right to receive royalty payments from sales of Namenda(R) (me...inical development for swelling associated with brain tumors. Additionally, nti has rights to two compounds in early-stage development for Alzheimer's and ...

Neurobiological Technologies Reports Receipt of $2.0 Million Royalty Payment for Quarterly Sales of Memantine

...antine for the treatment of moderate-to-severe Alzheimer's disease during the quarter ended December 31, 2007. Under an exclusive marketing agreement, nti currently receives quarterly royalty payments on certain sales of Memantine by Merz and its marketing partners. About Neurobiological Technologies, ...

Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens' Hospital

...30, 2008 of the royalties on sales of memantine in the third quarter of 2007 in the amount of $2,161,228. About Neurobiological Technologies, Inc. nti is a biopharmaceutical company focused on developing novel agents for central nervous system conditions. The Company's most advanced product candidate...

Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine

...emantine for the treatment of moderate-to-severe Alzheimer's disease for the quarter ended September 30, 2007. Under an exclusive marketing agreement, nti currently receives quarterly royalty payments on sales of Memantine by Merz and its marketing partners. Paul E. Freiman, President and CEO of Neurob...

Neurobiological Technologies Sets Date for Research and Development Day

...estions about the R&D Development Day can be directed to Walter Kass, NTI Investor Counsel, 212-300-4708. About Neurobiological Technologies, Inc. nti is a biopharmaceutical company focused on developing novel agents for central nervous system conditions. The Company's most advanced product candidate...

Update: Neurobiological Technologies Sets Date for Second Quarter Financial Results and Conference Call

...lay number: 888-203-1112 (U.S. and Canada) / 719-457-0820 (international). Replay access code: 3898964. About Neurobiological Technologies, Inc. nti is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stag...

Neurobiological Technologies Sets Date for Second Quarter Financial Results

...lay number: 888-203-1112 (U.S. and Canada) / 719-457-0820 (international). Replay access code: 3898964. About Neurobiological Technologies, Inc. nti is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stag...

Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from Board

...n advisor to the company and we are pleased that he has agreed to continue to be available to advise us." About Neurobiological Technologies, Inc. nti is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stag...

Neurobiological Technologies Announces Pricing of Its $60 Million Common Stock Offering

... sale would be unlawful prior to registration or qualification under the securities laws of any such state. About Neurobiological Technologies, Inc. nti is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stag...

Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split

...ates and receive new post-split certificates. Conference Call Information nti will web cast its year end financial results conference call on September 1...l), replay access code: 9278405. About Neurobiological Technologies, Inc. nti is a specialty biopharmaceutical company with expertise in identifying and ...

Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq

...and which is expected to close after the above-referenced 30-day cure period expires on September 28, 2007. About Neurobiological Technologies, Inc. nti is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stag...

Quantitation of GAD67 Gene Expression in Prefrontal Cortex of Schizophrenia Patients Using the iCycler iQ Detection System and Molecular Beacons, Rev A

...e PCR primers and molecular beacons were synthesized commercially (IDT Corporation, Coralville, IA). PCR primers were designed using Vector nti software (InforMax, North Bethesda, MD). The melting temperatures (T m ) of the primer and probe sequences were determined by Ol...
Other Tags
(Date:10/18/2014)... with undiagnosed, suspected genetic conditions, a certain type of ... diagnostic yield than traditional molecular diagnostic methods, according to ... is being released to coincide with the American Society ... sequences the protein­coding region of the genome (the complete ... cell or organism), has been rapidly applied in research ...
(Date:10/17/2014)... University of Copenhagen have shown for the first time ... Cystic fibrosis patients, giving them the opportunity to get ... infections. , The study also discovered the bacterial growth ... was halted or slowed down by the immune cells. ... oxygen and helped "suffocate" the bacteria, forcing the bacteria ...
(Date:10/16/2014)... Institute of Marine Science have received a 3-year, ... identify the streams and wetlands most vulnerable to ... local governments and citizens conserve these important ecosystems. ... of tidal-marsh observations first gathered by VIMS scientists ... can today,s researchers accurately map the slow but ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2EPA grant will help localities conserve headwater wetlands 2EPA grant will help localities conserve headwater wetlands 3
(Date:10/22/2014)... (PRWEB) October 22, 2014 Isabel ... of Allied Health Professions (ASAHP) Conference on October 22-24 ... CEO will participate in a panel discussion on Technology ... , Isabel Healthcare provides a diagnostic decision support tool ... the diagnosis skills of students and clinical learners. The ...
(Date:10/22/2014)... Oct. 21, 2014 (HealthDay News) -- The United ... arriving from Ebola-affected nations of West Africa land ... them for infection with the virus. In ... Johnson noted that 94 percent of air passengers ... at one of these five airports -- New ...
(Date:10/22/2014)... Hay House is pleased to announce the official ... Life (Paperback; $10.82) written by the highly esteemed Tommy Rosen, ... book is meant to help readers of all kinds end ... , Recovery 2.0 is not the average self-help book, or ... guide for what comes next. For many, Alcoholics ...
(Date:10/22/2014)... Best Cheap Hosting USA is among the most ... recently announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is the ... the world. , “iPower is one of the most ... various kinds of useful products for new and old ... customer service and a number of features which will ...
(Date:10/22/2014)... Although there are only 24 hours in a day, ... have trouble finding time within their busy schedules for exercise and ... of time to get in shape. Here are five ways you ... , Change Up Your Commute , Consider riding a bike ... exercise into your daily routine. If you must use your car ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2
Other Contents